BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
Balance Sheet
Inspect the capital base behind the business.
Assets
$632.65M
FY 2025 · Annual
+109.4% YoYLiabilities
$152.55M
FY 2025 · Annual
+13.6% YoYEquity
$480.11M
FY 2025 · Annual
+186.2% YoYBalance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $548.6M |
| Receivables | $74.9M |
| Inventory | $21.1M |
| Other Current | $6.7M |
| Total Current Assets | $651.4M |
| PP&E (Net) | $72.8M |
| Other Non-current | $5.6M |
| Total Non-current Assets | $78.3M |
| Total Assets | $729.7M |
Analysis
Selected assets total $729.7M for Latest. The largest visible component is Cash & Equivalents at $548.6M, about 75.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 10, 2026 | |
| SC 13D/A | SC 13D/A filing | Nov 9, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 |
How much cash does BLLN have?
BillionToOne, Inc. (BLLN) reported $495.98M in cash and equivalents in fiscal 2025.
How much debt does BLLN carry?
BillionToOne, Inc. (BLLN) reported $108.89M of total debt, with net debt of -$387.08M.
Continue the stock analysis
Jump to another research area for this company.